Product Information
The EGFR antibody is a highly effective monoclonal antibody that specifically targets the epidermal growth factor receptor (EGFR). It is designed to bind to the EGFR protein and inhibit its activity, thereby preventing the growth and proliferation of cancer cells. This antibody has been extensively studied in the field of life sciences and has shown promising results in various preclinical and clinical trials.
One of the key characteristics of this antibody is its high specificity for EGFR, ensuring minimal off-target effects. It has also demonstrated potent cytotoxic activity against cancer cells, making it an ideal candidate for targeted therapy. Additionally, studies have shown that this antibody exhibits in vivo antitumor activity, further validating its efficacy.
Furthermore, the EGFR antibody has been shown to enhance the effectiveness of platinum-based chemotherapy when used in combination. This combination therapy has proven to be particularly effective in treating certain types of cancer.
Another notable characteristic of this antibody is its ability to induce apoptosis (cell death) in cancer cells through a BH
Chemical properties
Technical inquiry about: 3D-20R-1940 EGFR antibody
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.